JUPITER NEUROSCIENCES, INC.
For the period ended Dec 31, 2025. Filed Apr 1, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 1, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on the signature page)
POWER OF ATTORNEY
Each person whose signature appears below hereby appoints Christer Rosén as attorney-in-fact with full power of substitution to execute in the name and on behalf of the registrant and each such person, individually and in each capacity stated below, one or more amendments to the Annual Report on Form 10-K, which amendments may make such changes in the report as the attorney-in-fact acting deems appropriate and to file any such amendment to the Annual Report on Form 10-K with the Securities and Exchange Commission. Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Christer Rosén | Chairman of the Board and Chief Executive Officer (principal executive officer) | April 1, 2026 |
| Christer Rosén | ||
| /s/ Saleem Elmasri | Chief Financial Officer (principal financial officer and principal accounting officer) | April 1, 2026 |
| Saleem Elmasri | ||
| /s/ Marshall Hayward, Ph.D. | Director | April 1, 2026 |
| Marshall Hayward, Ph.D. | ||
| /s/ Alison D. Silva | Director | April 1, 2026 |
| Alison D. Silva | ||
| /s/ Nicholas H. Hemmerly | Director | April 1, 2026 |
| Nicholas H. Hemmerly | ||
| /s/ Julie Kampf | Director | April 1, 2026 |
| Julie Kampf | ||
| /s/ Allison W. Brady | Director | April 1, 2026 |
| Allison W. Brady | ||
| /s/ Holger Weis | Director | April 1, 2026 |
| Holger Weis | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.